W ramach naszej witryny stosujemy pliki cookies w celu świadczenia Państwu usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że pliki opisane w Polityce Prywatności będą zamieszczane na Państwa urządzeniu końcowym. W każdej chwili możecie Państwo zmienić ustawienia dotyczące plików cookies w przeglądarce internetowej. Akceptacja niezbędnych plików cookies jest wymagana do prawidłowego działania witryny. Szczegółowe informacje znajdą Państwo w zakładce POLITYKA PRYWATNOŚCI.

Research Engineer (post-doc) in Innate Immunity Research Group

WYNAGRODZENIE :
OPIS STANOWISKA

Innate Immunity Research Group is looking for an ambitious and passionate candidate for the position of Postdoc to join the project founded by the National Science Center (NCN) Sonata Bis grant 2022/46/E/NZ6/00131 titled “Dissecting the tumoricidal potential of ILC2s in melanoma”. Doctoral degree must be obtained within 7 years before January 1 of the year of employment in the project". The project is led by dr. hab Marek Wagner. This position provides an excellent opportunity to become a part of a young research group dedicated to study a newly discovered group of immune cells termed group 2 innate lymphoid cells (ILC2s) in the context of melanoma, the most aggressive form of skin cancer.

Cancer is a major public health concern worldwide. Among the most common types of cancer are those, which manifest themselves in barrier tissues, including the skin. ILC2s reside primarily at such barrier tissues, yet their role in the development of the skin cancer is not fully established (Wagner et al., 2025 Nature). Based on our previous results, we hypothesize that the role of ILC2s in cancer is defined by the type of interactions within the tumor microenvironment. Therefore, our aim is to investigate the interactions between ILC2s and malignant and non-malignant stromal cells, using a variety of interdisciplinary approaches.

Our long-term research objective is to identify novel diagnostic and prognostic biomarkers in cancer as well as prospective therapeutic targets.         

CODZIENNE ZADANIA:

• Contributing to the ongoing project(s) with an opportunity to create your own niche.
• Designing and conducting experiments and analysing the obtained results.
• Staying up to date with the recent achievements of the field.
• Preparing reports and scientific articles and presenting results at institutional, regional, and/or international scientific meetings.

WYMAGANIA OBOWIĄZKOWE:

• Ph.D. in the area of experimental oncology, immunology or related discipline.
• Experience in flow cytometry and cell sorting.
• Very good English written and oral communication skills.
• Experience in molecular biology techniques (e.g. PCR, RT-PCR, ELISA, WB, transfection methods).
• Experience in immunohistochemistry and other tissue-based investigative methodologies.
• Prior experience in bioinformatics is a plus.
• Ability to work independently.
• Ability to collaborate with colleagues within the Group as well as with external partners (i.e. national and international).
• Commitment, responsibility and motivation.
• Meticulousness and attention to detail.
• Very good work organization.

Candidates are requested to submit:

 One-page cover letter explaining the reasons to join our team.
 Curriculum Vitae outlining research achievements and a record of publications.
 Contact information of two references.

BENEFITY:

• Full-time, fixed-term replacement contract with the possibility of further extension.
• Green science campus with free parking space.
• Excellent research facilities with modern and well-equipped laboratories.
• Strong collaboration with external partners (i.e. national and international).
• Competitive salary and social benefits: co-financing of private medical care, sport activities, etc.
• 36 days of paid annual leave.
• Friendly, inspiring, interdisciplinary environment with employees from different countries always ready to help.

aplikuj
[ninja_form id=17]

This will close in 0 seconds

This will close in 0 seconds